Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Current Opinion in Urology|October 15, 2019
Biological and therapeutic advances in the pursuit of effective immunotherapy for prostate cancerAnis A Hamid, Atish D ChoudhuryCurrent Oncology (Toronto, Ont.)|January 20, 2023
Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the LiteratureAlexius John, Lavinia Spain, Anis A HamidSeminars in Oncology Nursing|July 26, 2020
Nursing Implications of Recent Changes in Management Practices for Metastatic Prostate CancerCaitlin Bennett, Ian D Davis, Anis A HamidEuropean Urology Focus|December 19, 2018
Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New HorizonsAnis A Hamid, Michael J Morris, Ian D DavisAnnals of Palliative Medicine|September 6, 2018
Communicating prognosis of patients with advanced cancer between health care providers: a tertiary cancer center review of written correspondenceAnis A Hamid, Francis J Ha, Oindrila Das, et al.Urologic Oncology|April 13, 2024
Precision medicine for prostate cancer: An international perspectiveAnis A Hamid, Christopher J Sweeney, Christopher Hovens, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate CancerKoen Degeling, Niall M Corcoran, Amanda Pereira-Salgado, et al.Molecular Cancer Research : MCR|April 17, 2021
NF-κB Blockade with Oral Administration of Dimethylaminoparthenolide (DMAPT), Delays Prostate Cancer Resistance to Androgen Receptor (AR) Inhibition and Inhibits AR VariantsKatherine L Morel, Anis A Hamid, John G Clohessy, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 23, 2023
Metastatic Hormone-Sensitive Prostate Cancer: Toward an Era of Adaptive and Personalized TreatmentAnis A Hamid, Nicolas Sayegh, Bertrand Tombal, et al.European Urology Oncology|August 15, 2019
Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with ProstatectomyAnis A Hamid, Kathryn P Gray, Ying Huang, et al.Pageof 3